3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate (BioDeep_00000177768)

   

human metabolite blood metabolite


代谢物信息卡片


3-[2-({2-methoxy-3-[(octadecylcarbamoyl)oxy]propyl phosphono}oxy)ethyl]-1,3-thiazol-3-ium

  化学式: C28H53N2O7PS (592.3311)
中文名称: (±)-[3-(N-十八烷基氨基甲酰氧)-2-甲氧基]丙基-2- 噻唑乙基磷酸
  谱图信息: 最多检出来源 Homo sapiens(blood) 18.66%

分子结构信息

SMILES: CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)([O-])OCC[N+]1=CSC=C1)OC
InChI: InChI=1S/C28H53N2O7PS/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-29-28(31)35-24-27(34-2)25-37-38(32,33)36-22-20-30-21-23-39-26-30/h21,23,26-27H,3-20,22,24-25H2,1-2H3,(H-,29,31,32,33)


描述信息

D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors

同义名列表

6 个代谢物同义名

3-[2-({2-methoxy-3-[(octadecylcarbamoyl)oxy]propyl phosphono}oxy)ethyl]-1,3-thiazol-3-ium; 3-(N-N-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphoric acid; (R,S)-2-methoxy-3-(octadecyl-carbamoyloxy) propyl- 2-(3-thiazolio) ethyl phosphate; 2-Methoxy-3-(octadecylcarbamoyloxy)propyl-2-(3-thiazolinium) ethyl phosphate; 3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate; 3-MOTP



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome()

BioCyc()

PlantCyc()

代谢反应

个相关的代谢反应过程信息。

Reactome()

BioCyc()

WikiPathways()

Plant Reactome()

INOH()

PlantCyc()

COVID-19 Disease Map()

PathBank()

PharmGKB()

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Yu-Ren Liao, Ping-Chung Kuo, Wei-Jern Tsai, Guan-Jhong Huang, Kuo-Hsiung Lee, Tian-Shung Wu. Bioactive chemical constituents from the root bark of Morus australis. Bioorganic & medicinal chemistry letters. 2017 01; 27(2):309-313. doi: 10.1016/j.bmcl.2016.11.046. [PMID: 27908762]
  • Wei-Jern Tsai, Chien-Chang Shen, Tung-Hu Tsai, Lie-Chwen Lin. Lignans from the aerial parts of Saururus chinensis: isolation, structural characterization, and their effects on platelet aggregation. Journal of natural products. 2014 Jan; 77(1):125-31. doi: 10.1021/np400772h. [PMID: 24387347]
  • Scott D Ryan, Cory S Harris, Casey L Carswell, John E Baenziger, Steffany A L Bennett. Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. Journal of lipid research. 2008 Oct; 49(10):2250-8. doi: 10.1194/jlr.m800263-jlr200. [PMID: 18550892]
  • Soraya Imon de Oliveira, Patricia Dias Fernandes, João Gustavo P Amarante Mendes, Sonia Jancar. Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages. Prostaglandins & other lipid mediators. 2006 Jul; 80(1-2):62-73. doi: 10.1016/j.prostaglandins.2006.04.002. [PMID: 16846787]
  • Elzbieta Kolaczkowska, Susan Shahzidi, Rolf Seljelid, Nico van Rooijen, Barbara Plytycz. Early vascular permeability in murine experimental peritonitis is co-mediated by resident peritoneal macrophages and mast cells: crucial involvement of macrophage-derived cysteinyl-leukotrienes. Inflammation. 2002 Apr; 26(2):61-71. doi: 10.1023/a:1014837110735. [PMID: 11989789]
  • Kyoko Ishiguro, Satoko Nagata, Hisae Oku, Masae Yamaki. Bisxanthones from Hypericum japonicum: inhibitors of PAF-induced hypotension. Planta medica. 2002 Mar; 68(3):258-61. doi: 10.1055/s-2002-23125. [PMID: 11914965]
  • Y Ishihara, J B Zhang, S M Quinn, H A Schenkein, A M Best, S E Barbour, J G Tew. Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. Infection and immunity. 2000 Mar; 68(3):1563-8. doi: 10.1128/iai.68.3.1563-1568.2000. [PMID: 10678975]
  • T Michibayashi. Interaction between platelet-aggregating response and vasoconstrictive response to platelet activating factor. Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi. 1999 Aug; 35(4):111-24. doi: 10.1540/jsmr.35.111. [PMID: 10647808]
  • C S Venugopalan, R E Beadle, T L Seahorn, E P Holmes. Responses of guinea-pig lung parenchymal strips to tracheobronchial lavage fluid from horses affected with summer pasture-associated obstructive pulmonary disease. Veterinary research communications. 1998 Nov; 22(7):493-503. doi: 10.1023/a:1006131217140. [PMID: 9868763]
  • S A Bennett, H C Birnboim. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. Molecular carcinogenesis. 1997 Dec; 20(4):366-75. doi: 10.1002/(sici)1098-2744(199712)20:4<366::aid-mc6>3.0.co;2-h. [PMID: 9433481]
  • F Rougier, F Dupuis, E Cornu, C Dulery, V Praloran, Y Denizot. Platelet-activating factor and antagonists modulate DNA synthesis in human bone marrow stromal cell cultures. Journal of lipid mediators and cell signalling. 1997 Jul; 16(3):147-53. doi: 10.1016/s0929-7855(97)00576-2. [PMID: 9246604]
  • H E Bazan, Y Tao. PAF antagonists as possible inhibitors of corneal epithelial defects and ulceration. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics. 1997 Jun; 13(3):277-85. doi: 10.1089/jop.1997.13.277. [PMID: 9185044]
  • T Matsubara, K Yasuda, J M Johnston, M Sanezumi, H Okada, S Matsuoka, H Kanzaki. Platelet-activating factor (PAF) and PAF acetylhydrolase activity in rat uterus and placenta during the late stages of pregnancy. Biology of reproduction. 1997 Apr; 56(4):885-90. doi: 10.1095/biolreprod56.4.885. [PMID: 9096869]
  • G E Jarvis, R J Evans. Platelet-activating factor and not thromboxane A2 is an important mediator of endotoxin-induced platelet aggregation in equine heparinised whole blood in vitro. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis. 1996 Mar; 7(2):194-8. doi: 10.1097/00001721-199603000-00021. [PMID: 8735817]
  • M Calligerou, A Siafaka-Kapadai, D Galanopoulou, S T Weintraub, M Mavri-Vavayanni. Platelet activating factor and lyso-phosphatidylcholines from strawberry. Phytochemistry. 1996 Jan; 41(1):89-92. doi: 10.1016/0031-9422(95)00605-2. [PMID: 8588879]
  • S Okano, M Tagawa, N Urakawa. Effect of platelet activating factor antagonist (CV-3988) on 6-keto-PGF1 alpha and thromboxane B2 in dogs with experimental endotoxin-induced shock. The Journal of veterinary medical science. 1995 Feb; 57(1):81-5. doi: 10.1292/jvms.57.81. [PMID: 7756431]
  • M Furukawa, N Kubo, T Yamashita. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. The Laryngoscope. 1995 Feb; 105(2):188-91. doi: 10.1288/00005537-199502000-00015. [PMID: 8544602]
  • G E Jarvis, R J Evans. Endotoxin-induced platelet aggregation in heparinised equine whole blood in vitro. Research in veterinary science. 1994 Nov; 57(3):317-24. doi: 10.1016/0034-5288(94)90124-4. [PMID: 7871251]
  • F Bussolino, F Silvagno, G Garbarino, C Costamagna, F Sanavio, M Arese, R Soldi, M Aglietta, G Pescarmona, G Camussi. Human endothelial cells are targets for platelet-activating factor (PAF). Activation of alpha and beta protein kinase C isozymes in endothelial cells stimulated by PAF. The Journal of biological chemistry. 1994 Jan; 269(4):2877-86. doi: 10.1016/s0021-9258(17)42024-2. [PMID: 7507929]
  • M Watanabe, Y Arakida, J Tanabe, A Sugidachi, N Hirasawa, S Mue, K Ohuchi. Pharmacological analysis of neutrophil chemotactic factor production by leucocytes and roles of PAF in allergic inflammation in rats. British journal of pharmacology. 1994 Jan; 111(1):123-30. doi: 10.1111/j.1476-5381.1994.tb14033.x. [PMID: 8012688]
  • S A Bennett, L C Leite, H C Birnboim. Platelet activating factor, an endogenous mediator of inflammation, induces phenotypic transformation of rat embryo cells. Carcinogenesis. 1993 Jul; 14(7):1289-96. doi: 10.1093/carcin/14.7.1289. [PMID: 8392443]
  • D Yoshikawa, F Goto. Effect of platelet-activating factor antagonist and leukotriene antagonist on endotoxin shock in the rat: role of the leukocyte. Circulatory shock. 1992 Sep; 38(1):29-33. doi: NULL. [PMID: 1394861]
  • H Ikeuchi, T Sakano, J Sanchez, A D Mason, B A Pruitt. The effects of platelet-activating factor (PAF) and a PAF antagonist (CV-3988) on smoke inhalation injury in an ovine model. The Journal of trauma. 1992 Mar; 32(3):344-9; discussion 349. doi: 10.1097/00005373-199203000-00012. [PMID: 1548723]
  • H Iida, M Fujita, K Izumino, M Asaka, C Entani, M Takata, S Sasayama. Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat. Nephron. 1992; 60(4):471-6. doi: 10.1159/000186811. [PMID: 1584324]
  • T Imaizumi. Intravascular release of a platelet-activating factor-like lipid (PAF-LL) induced by cigarette smoking. Lipids. 1991 Dec; 26(12):1269-73. doi: 10.1007/bf02536545. [PMID: 1840278]
  • I Ikeda, M Oda, M Sakakura, K Yasunaga. Presence of platelet-activating factor in pyuria in humans. Lipids. 1991 Dec; 26(12):1333-5. doi: 10.1007/bf02536560. [PMID: 1819727]
  • A Tokumura, N Yube, M Terao, H Tsukatani. Antagonism of platelet-activating factor in isolated rat colon: possible mechanism. Lipids. 1991 Dec; 26(12):1344-6. doi: 10.1007/bf02536563. [PMID: 1819730]
  • A Arimura, M Harada. Differential effect of a PAF antagonist CV-3988 on active and passive anaphylactic shock in various mouse strains. Lipids. 1991 Dec; 26(12):1386-90. doi: 10.1007/bf02536572. [PMID: 1819738]
  • R Y Man, W M Hu, T Mock, A A Kinnaird. Effects of palmitoyl carnitine and structural analogs on arterial blood pressure in the rat. A comparison with platelet-activating factor. Journal of lipid mediators. 1991 Mar; 3(2):205-14. doi: NULL. [PMID: 1686730]
  • M Misawa, S C Huang, M H Chiu. The effect of platelet-activating factor on histamine release from guinea pig peritoneal mast cells. Journal of pharmacobio-dynamics. 1991 Feb; 14(2):61-5. doi: 10.1248/bpb1978.14.61. [PMID: 1714503]
  • Z W Hruby, R P Lowry, R D Forbes, D Blais. Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model. Archivum immunologiae et therapiae experimentalis. 1991; 39(5-6):575-86. doi: NULL. [PMID: 1668710]
  • E Kakishita, A Suehiro, Y Oura, K Nagai. Inhibitory effect of vitamin E (alpha-tocopherol) on spontaneous platelet aggregation in whole blood. Thrombosis research. 1990 Dec; 60(6):489-99. doi: 10.1016/0049-3848(90)90233-3. [PMID: 2082481]
  • A Arimura, M Nagata, A Watanabe, K Nakamura, M Takeuchi, M Harada. Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain. Experientia. 1990 Jul; 46(7):739-42. doi: 10.1007/bf01939952. [PMID: 2373200]
  • V L Marcheselli, M J Rossowska, M T Domingo, P Braquet, N G Bazan. Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex. The Journal of biological chemistry. 1990 Jun; 265(16):9140-5. doi: 10.1016/s0021-9258(19)38822-2. [PMID: 2160958]
  • R Verbesselt, T B Tjandra-Maga, P J De Schepper, K Itakura, T Sugiro. Determination of a platelet activating factor antagonist (CV-3988): methodology and clinical application. Journal of chromatography. 1990 Apr; 526(2):515-24. doi: 10.1016/s0378-4347(00)82533-5. [PMID: 2361990]
  • M Watanabe, A Sugidachi, M Omata, N Hirasawa, S Mue, S Tsurufuji, K Ohuchi. Possible role for platelet-activating factor in neutrophil infiltration in allergic inflammation in rats. International archives of allergy and applied immunology. 1990; 92(4):396-403. doi: 10.1159/000235171. [PMID: 2083975]
  • T Sasaki, S Shimura, K Ikeda, H Sasaki, T Takishima. Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland. The American journal of physiology. 1989 Dec; 257(6 Pt 1):L373-8. doi: 10.1152/ajplung.1989.257.6.l373. [PMID: 2692465]
  • F Guarner, J L Wallace, W K MacNaughton, G C Ibbotson, V Arroyo, J Rodés. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. Hepatology (Baltimore, Md.). 1989 Nov; 10(5):788-94. doi: 10.1002/hep.1840100507. [PMID: 2807157]
  • A Subissi, M Del Monte, S Evangelista, P Santicioli, M Criscuoli. Octylonium bromide, an antagonist of platelet-activating factor. Archives internationales de pharmacodynamie et de therapie. 1989 Nov; 302(?):255-67. doi: NULL. [PMID: 2636821]
  • G Danko, J E Sherwood, B Grissom, W Kreutner, R W Chapman. Effect of the PAF antagonists, CV-3988 and L-652,731 on the pulmonary and hematological responses to guinea pig anaphylaxis. Pharmacological research communications. 1988 Sep; 20(9):785-98. doi: 10.1016/s0031-6989(88)80717-3. [PMID: 3174804]
  • G Grue-Sørensen, I M Nielsen, C K Nielsen. Derivatives of 2-methylenepropane-1,3-diol as new antagonists of platelet activating factor. Journal of medicinal chemistry. 1988 Jun; 31(6):1174-8. doi: 10.1021/jm00401a017. [PMID: 3373485]
  • J Arnout, A van Hecken, I De Lepeleire, Y Miyamoto, I Holmes, P De Schepper, J Vermylen. Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. British journal of clinical pharmacology. 1988 Apr; 25(4):445-51. doi: 10.1111/j.1365-2125.1988.tb03328.x. [PMID: 3289599]
  • Y Okuda, I Tsuyuguchi, A Yamatodani. Histamine release from human leukocytes by platelet-activating factor. International archives of allergy and applied immunology. 1988; 85(3):341-5. doi: 10.1159/000234529. [PMID: 2450844]
  • T Kobayashi, H Hohnoki, Y Esumi, T Ohtsuki, T Washino, S Tanayama. Metabolism and disposition of (RS)-2-methoxy-3-(octadecylcarbamoyloxy)propyl 2-(3-thiazolio)ethyl phosphate (MOTP) in rats and dogs. Xenobiotica; the fate of foreign compounds in biological systems. 1988 Jan; 18(1):49-59. doi: 10.3109/00498258809055136. [PMID: 3354232]
  • J Steiger, M A Bray, N Subramanian. Platelet activating factor (PAF) is a potent stimulator of porcine tracheal fluid secretion in vitro. European journal of pharmacology. 1987 Oct; 142(3):367-72. doi: 10.1016/0014-2999(87)90075-6. [PMID: 3428351]
  • Z Terashita, Y Imura, A Shino, K Nishikawa. A lethal role of platelet activating factor in anaphylactic shock in mice. The Journal of pharmacology and experimental therapeutics. 1987 Oct; 243(1):378-83. doi: NULL. [PMID: 3118009]
  • J L Wallace, G Steel, B J Whittle, V Lagente, B Vargaftig. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat. Effects of three platelet-activating factor antagonists. Gastroenterology. 1987 Oct; 93(4):765-73. doi: 10.1016/0016-5085(87)90438-0. [PMID: 3305134]
  • B Dewald, M Baggiolini. Evaluation of PAF antagonists using human neutrophils in a microtiter plate assay. Biochemical pharmacology. 1987 Aug; 36(15):2505-10. doi: 10.1016/0006-2952(87)90523-5. [PMID: 3649232]
  • J L Wallace, G Steel, B J Whittle. Gastrointestinal plasma leakage in endotoxic shock. Inhibition by prostaglandin E2 and by a platelet-activating factor antagonist. Canadian journal of physiology and pharmacology. 1987 Jul; 65(7):1428-32. doi: 10.1139/y87-224. [PMID: 3478114]
  • S Adnot, D Joseph, B B Vargaftig. Antagonists of PAF-acether do not suppress thrombin-induced aggregation of ADP-deprived and aspirin-treated human platelets. Agents and actions. 1987 Jun; 21(1-2):195-202. doi: 10.1007/bf01974942. [PMID: 3115070]
  • A Tokumura, J Yoshida, T Maruyama, K Fukuzawa, H Tsukatani. Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor. Thrombosis research. 1987 Apr; 46(1):51-63. doi: 10.1016/0049-3848(87)90206-4. [PMID: 3647677]
  • A Tokumura, J Yoshida, N Okasaka, K Fukuzawa, H Tsukatani. Platelet aggregation induced by ether-linked phospholipids. 2. Mechanism of desensitization of rabbit platelets by platelet activating factor and reversibility of inhibitory actions of its antagonists. Thrombosis research. 1987 Apr; 46(1):153-61. doi: 10.1016/0049-3848(87)90215-5. [PMID: 3590110]
  • P E Malo, M A Wasserman, D F Pfeiffer. Enhancement of leukotriene D4-induced contraction of guinea-pig isolated trachea by platelet activating factor. Prostaglandins. 1987 Feb; 33(2):209-25. doi: 10.1016/0090-6980(87)90007-4. [PMID: 3588971]
  • M Watanabe, K Ohuchi, A Sugidachi, N Hirasawa, Y Hayashi, S Tsurufuji. Platelet-activating factor in the inflammatory exudate in the anaphylactic phase of allergic inflammation in rats. International archives of allergy and applied immunology. 1987; 84(4):396-403. doi: 10.1159/000234456. [PMID: 3119503]
  • S B Hwang, M H Lam. Species difference in the specific receptors of platelet activating factor. Biochemical pharmacology. 1986 Dec; 35(24):4511-8. doi: 10.1016/0006-2952(86)90772-0. [PMID: 3024653]
  • J Yoshida, A Tokumura, K Fukuzawa, M Terao, K Takauchi, H Tsukatani. A platelet-aggregating and hypotensive phospholipid isolated from bovine brain. The Journal of pharmacy and pharmacology. 1986 Dec; 38(12):878-82. doi: 10.1111/j.2042-7158.1986.tb03375.x. [PMID: 2880959]
  • I Ono, T Ohura, K Azami, M Hoshi, T Hasegawa, M Tsutsumi. The effect of drugs which affect the arachidonate cascade in burned rabbits. Burns, including thermal injury. 1986 Dec; 12(8):572-7. doi: 10.1016/0305-4179(86)90008-2. [PMID: 3136865]
  • D Nunez, M Chignard, R Korth, J P Le Couedic, X Norel, B Spinnewyn, P Braquet, J Benveniste. Specific inhibition of PAF-acether-induced platelet activation by BN 52021 and comparison with the PAF-acether inhibitors kadsurenone and CV 3988. European journal of pharmacology. 1986 Apr; 123(2):197-205. doi: 10.1016/0014-2999(86)90660-6. [PMID: 3086108]
  • D B Buxton, D J Hanahan, M S Olson. Specific antagonists of platelet activating factor-mediated vasoconstriction and glycogenolysis in the perfused rat liver. Biochemical pharmacology. 1986 Mar; 35(6):893-7. doi: 10.1016/0006-2952(86)90073-0. [PMID: 3754140]
  • A C Issekutz, M Szpejda. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988. Laboratory investigation; a journal of technical methods and pathology. 1986 Mar; 54(3):275-81. doi: NULL. [PMID: 3951199]
  • D A Handley, C Farley, R W Deacon, R N Saunders. Evidence for distinct systemic extravasation effects of platelet activating factor, leukotrienes B4, C4, D4 and histamine in the guinea pig. Prostaglandins, leukotrienes, and medicine. 1986 Mar; 21(3):269-77. doi: 10.1016/0262-1746(86)90048-x. [PMID: 3010331]
  • D A Handley, M L Lee, R N Saunders. Evidence for a direct effect on vascular permeability of platelet-activating factor induced hemoconcentration in the guinea pig. Thrombosis and haemostasis. 1985 Dec; 54(4):756-9. doi: 10.1055/s-0038-1660126. [PMID: 4089809]
  • F Masugi, T Ogihara, S Saeki, A Otsuka, Y Kumahara. Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats. Hypertension (Dallas, Tex. : 1979). 1985 Sep; 7(5):742-6. doi: 10.1161/01.hyp.7.5.742. [PMID: 4030044]
  • T Matsudaira, H Kogo, T Satoh. A possible role of antihypertensive polar renomedullary lipid (APRL) and prostaglandin E2 in the kidney in the antihypertensive action of pindolol. Research communications in chemical pathology and pharmacology. 1985 Jul; 49(1):65-9. doi: NULL. [PMID: 3862195]
  • F Masugi, T Ogihara, A Otsuka, S Saeki, Y Kumahara. The role of antihypertensive polar renomedullary lipid in the pathogenesis of hypertension. Japanese circulation journal. 1984 Feb; 48(2):196-200. doi: 10.1253/jcj.48.196. [PMID: 6366289]
  • F Masugi, T Ogihara, A Otsuka, S Saeki, Y Kumahara. Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. Life sciences. 1984 Jan; 34(2):197-201. doi: 10.1016/0024-3205(84)90591-5. [PMID: 6694519]
  • F M Lueck. An overview of renal oxalosis. Nephrology nurse. 1980 May; 2(3):13-4. doi: NULL. [PMID: 6991966]
  • M Sano. Subcellular localizations of guanylate cyclase and 3',5'-cyclic nucleotide phosphodiesterase in sea urchin sperm. Biochimica et biophysica acta. 1976 Apr; 428(2):525-31. doi: 10.1016/0304-4165(76)90061-1. [PMID: 6049]
  • I M Nilsson, S E Bergentz, U Hedner, K Kullenberg. Gastric fibrinolysis. Thrombosis et diathesis haemorrhagica. 1975 Nov; 34(2):409-18. doi: 10.1055/s-0038-1651400. [PMID: 807]